Mylan launches generic version of Forest Labs' Lexapro

PITTSBURGH — Mylan has launched a generic drug for treating depression and anxiety, the company said Wednesday.



Mylan announced the launch of escitalopram tablets in the 5-mg, 10-mg and 20-mg strengths, the first generic version of Forest Labs' Lexapro. The drug is used for treating major depressive disorder and generalized anxiety disorder.



Lexapro had sales of about $2.9 billion in 2011, according to IMS Health. Mylan said it would market its version exclusively until Lexapro's period of market exclusivity for use in children expires, according to an agreement between Forest Labs and Mylan's Alphapharm subsidiary.

Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.